BIRC5 and hepatocellular carcinoma: Birc5 was a potential biomarker and inducer of intratumor infiltration of MDSCs, which led to T‐cell exclusion or dysfunction in tumor immune microenvironment, consequently resulting in reduced response to ICIs in HCC.